Xenta Drug Screen Cup, Xenta Drug Screen Dipcard— 510(k) K222955

Name: FDA 510(k) clearance K222955
Creator: U.S. Food and Drug Administration
Published: 2023-02-06

Substantially Equivalent

Xenta Biomedical Science Co., Ltd.

FDA 510(k) clearance K222955 for Xenta Drug Screen Cup, Xenta Drug Screen Dipcard, Substantially Equivalent on 2023-02-06. Applicant: Xenta Biomedical Science Co., Ltd.. Device class: 2.

Clearance details

Applicant: Xenta Biomedical Science Co., Ltd.
Product code: Code DJG
Device class: Class 2
Regulation: 21 CFR 862.3650
Advisory panel: Clinical Toxicology
Date received: 2022-09-27
Decision date: 2023-02-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Guangzhou, CN

Download summary PDF View on FDA.gov ↗

Recent devices under product code DJG

view all

K252684 — Labcorp Fentanyl Urine Visual Test2026-01-29
K250741 — Evidence MultiSTAT DOA Urine MultiPlex2026-01-23
K253082 — LZI Buprenorphine II Enzyme Immunoassay2026-01-16
K252520 — SEFRIA Hydrocodone Oral Fluid2025-09-11
K251972 — Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative +1 more2025-08-15

More clearances from Xenta Biomedical Science Co., Ltd.

view all

K231137 — Xenta Drug Screen Cup, Xenta Drug Screen Dipcard2023-05-19

Data sourced from openFDA. This site is unofficial and independent of the FDA.